Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31652590 | 0.94 | MAOA (0.33) | HRH4HRH3 | |
| SCHEMBL15228417 | 0.92 | HRH1 (0.34) | HRH4HRH3 | |
| SCHEMBL4174560 | 0.92 | HRH1 (0.34) | HRH4HRH3 | |
| Hydrochloric Acid SCHEMBL28319672 | 0.90 | HRH1 (0.33) | HRH4HRH3 | |
| SCHEMBL1044610 | 0.87 | — | — | |
| SCHEMBL5703319 | 0.87 | STAT3 (0.31) | — | |
| SCHEMBL548121 | 0.87 | STAT3 (0.35) | — | |
| SCHEMBL10626678 | 0.86 | GSK3A (0.37) | HRH4HRH3 | |
| Trifluoroacetic Acid SCHEMBL28288442 | 0.85 | HRH4 (0.47) | HRH4HRH3 | |
| Hydrochloric Acid SCHEMBL15994560 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215041-A1 | System and Method for Aqueous Conjugation of Substrates Using Diels-Alder Chemistry | Life Technologies Corporation | 2025-07-03 | — | — | US | disclosed |
| US-20250215045-A1 | SYSTEM AND METHOD FOR AQUEOUS CONJUGATION OF SUBSTRATES | Life Technologies Corporation | 2025-07-03 | — | — | US | disclosed |
| US-11926854-B2 | Soluble intein fusion proteins and methods for purifying biomolecules | MERCK PATENT GMBH (DE) | 2024-03-12 | — | — | US | disclosed |
| US-20220267750-A1 | Soluble Intein Fusion Proteins And Methods For Purifying Biomolecules | MERCK PATENT GMBH (DE) | 2022-08-25 | — | — | US | disclosed |
| US-11326154-B2 | Soluble intein fusion proteins and methods for purifying biomolecules | MERCK PATENT GMBH (DE) | 2022-05-10 | — | — | US | disclosed |
| US-10723731-B2 | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-07-28 | — | — | US | disclosed |
| US-10442930-B2 | Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels | VISEN MEDICAL, INC. (US) | 2019-10-15 | — | — | US | disclosed |
| EP-1934202-B1 | NICOTINIC ACID AND PICOLINIC ACID DERIVED NEAR-INFRARED FLUOROPHORES | VISEN MEDICAL INC (US) | 2019-01-09 | — | — | EP | disclosed |
| US-20180186792-A1 | HETEROBIFUNCTIONAL LINKERS WITH POLYETHYLENE GLYCOL SEGMENTS AND IMMUNE RESPONSE MODIFIER CONJUGATES MADE THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2018-07-05 | — | — | US | disclosed |
| US-9902724-B2 | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-02-27 | — | — | US | disclosed |
| EP-1934211-A1 | BIOCOMPATIBLE N, N-DISUBSTITUTED SULFONAMIDE-CONTAINING FLUORESCENT DYE LABELS | Visen Medical, Inc. (US) | 2008-06-25 | — | — | EP | disclosed |
| EP-1934202-A2 | NICOTINIC ACID AND PICOLINIC ACID DERIVED NEAR-INFRARED FLUOROPHORES | Visen Medical, Inc. (US) | 2008-06-25 | — | — | EP | disclosed |
| CN-1307263-C | Fluorescent dye, method and kit for saturation labeling of proteins | AMOSEN BIOLOG SCIENCE BRITISH (GB) | 2007-03-28 | — | — | CN | disclosed |
| WO-2007028037-A1 | BIOCOMPATIBLE N, N-DISUBSTITUTED SULFONAMIDE-CONTAINING FLUORESCENT DYE LABELS | VISEN MEDICAL, INC. (US) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007028163-A1 | BIOCOMPATIBLE FLUORESCENT IMAGING AGENTS | VISEN MEDICAL, INC. (US) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007028118-A2 | NICOTINIC ACID AND PICOLINIC ACID DERIVED NEAR-INFRARED FLUOROPHORES | VISEN MEDICAL, INC. (US) | 2007-03-08 | — | — | WO | disclosed |
| US-20050233462-A1 | Reagents and a method for saturation labelling of proteins | GLOBAL LIFE SCIENCES SOLUTIONS GERMANY GMBH (DE) | 2005-10-20 | — | — | US | disclosed |
| CN-1650168-A | Reagents and methods for saturation labelling of proteins | AMOSEN BIOLOG SCIENCE BRITISH (GB) | 2005-08-03 | — | — | CN | disclosed |
| EP-1520176-A1 | REAGENTS AND A METHOD FOR SATURATION LABELLING OF PROTEINS | Amersham Biosciences UK Limited (GB) | 2005-04-06 | — | — | EP | disclosed |
| WO-2004005933-A1 | REAGENTS AND A METHOD FOR SATURATION LABELLING OF PROTEINS | AMERSHAM BIOSCIENCES UK LIMITED (GB) | 2004-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10723731-B2 | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom | IL2, ICOS, CD40 | HRH4 381/4885HRH3 463/4885 |
| US-20050233462-A1 | Reagents and a method for saturation labelling of proteins | SET, IK, MRPS22 | HRH4 303/4885HRH3 237/4885 |
| US-20250215041-A1 | System and Method for Aqueous Conjugation of Substrates Using Diels-Alder Chemistry | AS3MT, DNMT1, RNGTT | HRH4 1786/4885HRH3 2563/4885 |
| US-20250215045-A1 | SYSTEM AND METHOD FOR AQUEOUS CONJUGATION OF SUBSTRATES | RNGTT, HNMT, FPGS | HRH4 600/4885HRH3 335/4885 |
| US-20180186792-A1 | HETEROBIFUNCTIONAL LINKERS WITH POLYETHYLENE GLYCOL SEGMENTS AND IMMUNE RESPONSE MODIFIER CONJUGATES MADE THEREFROM | IL2, ICOS, CD40 | HRH4 381/4885HRH3 463/4885 |
| US-10442930-B2 | Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels | DNPEP, FUT5, NES | HRH4 2265/4885HRH3 1806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.